Services
Research and Clinical Development
Regulatory
Clinical
Biometrics
CMC
Consulting
Management Consulting
Market Access
Patient Engagement
Transaction Advisory
Lifecycle Optimization
Lifecycle Optimization
Real-World Solutions
Real-World Solutions
Biotech
Biotech
Technology
Clini-Sight
A virtual site addition that enables faster, more diverse, and more efficient clinical studies.
Evi-Sight
A digital Real-World Evidence (RWE) platform that collects and curates data that offers insight into the patient experience, clinical outcomes, patient behavior, and decision-making.
Care-Sight
A digital platform for Patient Support Programs (PSPs) and digital therapeutics (DTx).
Health Storylines
A patient-driven digital operating system that covers multiple use-cases from decentralized clinical trials (DCT) to Real-World Evidence (RWE) generation, and patient support programs.
About
Meet Our Team
Our team collaborates to fully understand every aspect of each client’s organization from concept ideation to commercial realization, from innovation to implementation
Community Involvement
We work with our local and global communities to create positive change through education, service, and sustainable business practices
800+
employees
90+%
has a PhD and/or Masters
15
languages spoken
30
nationalities
Careers
Resources
News
Read all the latest from us
Blog
Gain insights on healthcare innovation and more
Publications
Discover our latest industry infographics, articles, white papers, and more
Multimedia
Visit our videos, podcasts, webinars, and more
Case Studies
Learn how we deliver meaningful results for clients
Latest in the hub
Closing the Loop: An Overview of Three Business Models in Diabetes Disease Management Devices
Published: December, 2023
Handling Uncertainty in Health-Economic Assessments: Experience from COVID-19 in France
Published: December, 2023
How to Accelerate Lupus Solutions with RWD
Published: November, 2023
Services
Overview
Research and Clinical Development
Regulatory Clinical Biometrics CMC
Consulting
Management Consulting Market Access Patient Engagement Transaction Advisory Lifecycle Optimization
Real-World Solutions
Real-World Solutions
Biotech
Biotech
Technology
Overview Clini-Sight Evi-Sight Care-Sight Health Storylines
About
Overview Meet Our Team Community Involvement
Careers
Resources
Overview News Blog Publications Multimedia Case Studies
Home > Education Hub > Pre-Commercial Value Assessment of a Nuclear Medicine Pair to Diagnose and Treat Neuroendocrine Tumors (NET)

Pre-Commercial Value Assessment of a Nuclear Medicine Pair to Diagnose and Treat Neuroendocrine Tumors (NET)

Publications
Category:
Pharma
Published on:
August 1, 2020
Written by:
Piergiulio Lauriano

When our client, a leading radiopharmaceutical company, needed support to understand the commercial opportunity represented by a Phase III radiopharmaceutical and its diagnostic radiotracer companion, Alira Health stepped in to run a comprehensive analysis.

Read on to learn how our team analyzed the market, assessed value assets, and helped our client move forward with confidence.

For more information, please contact Piergiulio Lauriano.

For more information about Alira Health’s Management Consulting services

Click here

Related news

Blog November 17, 2023
Misconceptions About Patient-Centric Co-Design
Many people have misconceptions about patient-centric co-design, and these misconceptions are holding companies back.
Co-Design Digital Health MedTech Patient Centricity Pharma
Blog November 2, 2023
The Impact of New Treatment Approvals in Oncology on Relative Survival Rates for EU Patients
This article explores the relationship between the number of new cancer treatment approvals and the five-year relative survival of cancer patients across the European Union (EU).
Oncology Pharma
Blog October 16, 2023
How to Co-Design a Solution with Patients to Meet Their Needs
To learn how you can benefit from a co-design approach and how to get started, we spoke with two experts on patient engagement and co-design.
Digital Health MedTech Patient Centricity Patient Engagement Pharma
Blog October 9, 2023
Inflation Reduction Act and Pharma – Navigating Uncertainty
What's the impact of the Inflation Reduction Act on small biotechs, mid-size companies and large pharma players, and how can they prepare?
Biotech Pharma
Publications September 19, 2023
Opportunities and Challenges in the Therapeutic and CDMO Markets
Our Transaction Advisory experts have analyzed the CDMO industry trends, M&A activities, and projected growth in this CHEManager article.
CDMO Pharma
News August 31, 2023
Alira Health Named One of the World’s Best Management Consulting Firms by Forbes
Alira Health is proud to announce it has been named by Forbes as one of the World’s Best Management Consulting Firms for 2023.
Life Sciences MedTech Pharma Press Release
Publications August 1, 2023
The EU Pharmaceutical Package: Impact on Orphan Medicinal Products
This article reviews the proposed changes in the EU Pharma Package for data protection related to orphan medicinal products (OMPs).
EU Pharma Regulatory
See all news
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.